Drug: Cannabis: chronic pain clinical trials
Registry records that list "Drug: Cannabis" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Cannabis Vs Opioids Pain Management Objective Testing Comparisons NCT03734731 | Not yet recruiting | Not applicable | American Association of Sensory Electrodiagnostic Medicine | 2026-06-03 | |
| Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain NCT04827992 | Completed | Not applicable | United States | Massachusetts General Hospital | 2021-08-23 |
| Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease NCT01771731 | Completed | Phase 1, Phase 2 | United States | University of California, San Francisco | 2014-08 |
| Opioid and Cannabinoid Pharmacokinetic Interactions NCT00308555 | Completed | Phase 1 | United States | University of California, San Francisco | 2006-05 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.